InspireMD (NSPR) Net Cash Flow Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -101.09% |
| Sep 30, 2025 | 80.70% |
| Jun 30, 2025 | -15.79% |
| Mar 31, 2025 | -22.84% |
| Dec 31, 2024 | 31.09% |
| Sep 30, 2024 | -49.23% |
| Jun 30, 2024 | 25.94% |
| Mar 31, 2024 | 41.40% |
| Dec 31, 2023 | -18.75% |
| Sep 30, 2023 | -13.15% |
| Jun 30, 2023 | -79.11% |
| Mar 31, 2023 | -19.26% |
| Dec 31, 2022 | 21.53% |
| Sep 30, 2022 | -3.11% |
| Jun 30, 2022 | 6.28% |
| Mar 31, 2022 | -42.75% |
| Dec 31, 2021 | 18.48% |
| Sep 30, 2021 | -37.73% |
| Jun 30, 2021 | -18.71% |
| Mar 31, 2021 | 93.24% |
| Dec 31, 2020 | 20.54% |
| Jun 30, 2020 | 38.66% |
| Mar 31, 2020 | -18.53% |
| Mar 31, 2019 | 1.32% |
| Sep 30, 2018 | 27.75% |
| Jun 30, 2018 | -27.83% |
| Mar 31, 2018 | 18.31% |
| Dec 31, 2017 | 18.56% |
| Sep 30, 2017 | -1.22% |
| Mar 31, 2017 | 21.25% |
| Dec 31, 2016 | -1.40% |
| Sep 30, 2016 | 92.37% |
| Jun 30, 2016 | 6.64% |
| Mar 31, 2016 | -16.44% |
| Dec 31, 2015 | -77.06% |